[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355834-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355834-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mettl3-mediated-m6a-modification-stabilizes-circcdk6-to-promote-cervical-cancer-tumorigenesis-via-the-mir-449acdk6-axis","METTL3-mediated m6A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis","","Cervical cancer remains a major global health burden. This study tests whether the RNA methyltransferase METTL3 promotes cervical cancer progression by regulating circCDK6 stability through N6-methyladenosine (m6A). Analyses of patient samples and functional assays in vitro and in vivo show METTL3 and circCDK6 upregulation, linking high expression with advanced disease and poor prognosis. METTL3 binds circCDK6, installs m6A, and increases circCDK6 stability, while METTL3/circCDK6 knockdown suppresses proliferation and tumor growth. Mechanistically, circCDK6 sponges miR-449a to de-repress CDK6. Results define an oncogenic METTL3/m6A/circCDK6/miR-449a/CDK6 axis and highlight therapeutic targeting potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mettl3-mediated-m6a-modification-stabilizes-circcdk6-to-promote-cervical-cancer-tumorigenesis-via-the-mir-449acdk6-axis/355834/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mettl3-mediated-m6a-modification-stabilizes-circcdk6-to-promote-cervical-cancer-tumorigenesis-via-the-mir-449acdk6-axis/355834.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the central hypothesis of the study?","Question",{"text":63,"@type":64},"METTL3 may regulate circCDK6 stability and oncogenic function in cervical cancer by depositing m6A modifications.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do the authors connect METTL3 and circCDK6?",{"text":68,"@type":64},"METTL3 directly binds circCDK6 and installs m6A, which enhances circCDK6 RNA stability.",{"name":70,"@type":61,"acceptedAnswer":71},"What downstream pathway does circCDK6 activate?",{"text":72,"@type":64},"circCDK6 acts as a competitive endogenous RNA that sponges miR-449a, thereby de-repressing CDK6, a key cell cycle regulator.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355834,1790813945,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMETTL3-mediated m6A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/ CDK6 axis  \nPeilinZhong1,2, Wenbo Li3, Mei Feng2, Aihua Guo2, Linhua Wang2 & Zhongjun Wu1􀀍  \nCervical cancer remains a significant global health burden. This study aimed to investigate whether the RNA methyltransferase METTL3 promotes cervical cancer progression by regulating the  \nstability of circular RNA circCDK6 via N⁶-methyladenosine (m⁶A) modification. Clinical samples from cervical cancer patients were analyzed. In vitro and in vivo functional assays, including PCR, RNA immunoprecipitation, m⁶A-methylated RNA immunoprecipitation, RNA stability assays, CCK-8, colony formation, flow cytometry, dual-luciferase reporter assay, and xenograft models were employed using cervical cancer cell lines. METTL3 and circCDK6 were significantly upregulated in cervical cancer tissues, and high expression correlated with advanced disease and poor patient prognosis. METTL3 directly bound to circCDK6 and installed m⁶A modification, which enhanced circCDK6 RNA stability. Knockdown of METTL3 or circCDK6 suppressed cell proliferation, induced G0/G1 phase arrest, and inhibited tumor growth in mouse models. Mechanistically, circCDK6 functioned as a competitive endogenous RNA to sponge miR-449a, thereby de-repressing the expression of its target, CDK6, a key cell cycle regulator. Our findings unveil a novel oncogenic METTL3/m⁶A/circCDK6/miR-449a/CDK6 axis that promotes cervical cancer tumorigenesis, highlighting its potential as a therapeutic target for intervention.  \nKeywords Cervical cancer, METTL3, m6A, circCDK6, CDK6, miRNA sponge  \nCervical cancer remains a major threat to women’s health globally, with persistent infection of high-risk human papillomavirus (HR-HPV) being the primary etiological factor1. Despite the widespread implementation of screening and prophylactic HPV vaccination, which have significantly reduced the incidence and mortality in developed countries, patients with advanced or recurrent disease still face a dismal prognosis due to limited therapeutic options2,3. This underscores the urgent need to elucidate the intricate molecular mechanisms driving cervical carcinogenesis and to identify novel diagnostic biomarkers and therapeutic targets.  \nIn recent years, non-coding RNAs have emerged as pivotal regulators in cancer biology. Among them, circular RNAs (circRNAs), characterized by their covalently closed loop structure, exhibit high stability and conservation4. Functioning primarily as competitive endogenous RNAs (ceRNAs), circRNAs can sequester microRNAs (miRNAs), thereby derepressing the expression of downstream target genes and influencing various cellular processes, including tumorigenesis5,6. Growing evidence has highlighted the aberrant expression and critical roles of numerous circRNAs in cervical cancer7,8. Our previous study identified circCDK6, derived from the cyclin-dependent kinase 6 (CDK6) gene locus, as being significantly upregulated in cervical cancer cells, where it promotes proliferation and metastasis by sponging miR-449a9. CDK6 is a key regulator of the G1/S cell cycle transition and a well-established oncoprotein. However, the upstream regulatory mechanisms controlling circCDK6 itself in cervical cancer remain largely unknown.  \nN6-methyladenosine (m6A), the most prevalent internal mRNA modification in eukaryotes, represents another layer of post-transcriptional regulation10. This dynamic and reversible process, catalyzed by “writer”  \n1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, No.1 YouYi Road, Chongqing 400016, China. 2Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China. 3Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 4000","cbCailYQvDURGee5","https://ap.wps.com/l/cbCailYQvDURGee5","pdf",3182114,16,"English","# Background\n## Circular RNAs and ceRNA function in cancer\n## m6A modification as post-transcriptional regulation\n# Study Rationale and Aim\n## Hypothesis and objectives\n# Key Findings and Mechanistic Model\n## METTL3/circCDK6 upregulation and prognosis\n## m6A deposition stabilizes circCDK6\n## circCDK6 sponges miR-449a to activate CDK6\n# Conclusion\n## Oncogenic axis and therapeutic potential","[{\"question\":\"What is the central hypothesis of the study?\",\"answer\":\"METTL3 may regulate circCDK6 stability and oncogenic function in cervical cancer by depositing m6A modifications.\"},{\"question\":\"How do the authors connect METTL3 and circCDK6?\",\"answer\":\"METTL3 directly binds circCDK6 and installs m6A, which enhances circCDK6 RNA stability.\"},{\"question\":\"What downstream pathway does circCDK6 activate?\",\"answer\":\"circCDK6 acts as a competitive endogenous RNA that sponges miR-449a, thereby de-repressing CDK6, a key cell cycle regulator.\"}]","METTL3-mediated m6A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis | PDF",1790121253,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad8d90601940a9ca8b2adca9d8623f2e.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e4d817071e0cff627cfefd01ff53bb8.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/850c970948efa1327e28367be4744b75.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c188cf7897f86beba5817dd5c3da9f6.webp",980,1287]